| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,216 |
8,216 |
$486K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,433 |
2,951 |
$244K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,437 |
5,718 |
$168K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,391 |
2,035 |
$144K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,304 |
2,659 |
$60K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,442 |
3,074 |
$34K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
304 |
259 |
$28K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
191 |
187 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
71 |
66 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
54 |
47 |
$1K |
| 87807 |
|
124 |
97 |
$877.75 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19 |
15 |
$221.49 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
16 |
12 |
$200.02 |
| 81003 |
|
113 |
73 |
$68.65 |
| 99000 |
|
246 |
224 |
$0.00 |
| 99072 |
|
423 |
349 |
$0.00 |